Patrick Enright
SelectiveNamed in filings at Longitude CapitalOn the current fund
- Board seats filed
- 18
Named in filings at Longitude CapitalOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Infinant Health | Biotech & pharma | May 2026 | None on file |
| Veradermics | Biotech & pharma | November 2024 | None on file |
| BioAge Labs | Biotech & pharma | February 2024 | Gran Paradiso Capital Partners, Sofinnova Venture Partners |
| Zenas BioPharma (Cayman) | Biotech & pharma | November 2022 | Vivo Innovation |
| Endeavor Biomedicines | Biotech & pharma | January 2022 | None on file |
| Vera Therapeutics | Biotech & pharma | October 2020 | Sofinnova Venture Partners, Westlake Biopartners |
| Stichting Administratiekantoor syncreon | Logistics & supply chain | October 2020 | None on file |
| Rivus Pharmaceuticals | Biotech & pharma | March 2019 | None on file |
| CuraSen Therapeutics | Biotech & pharma | September 2018 | New Leaf |
| Rockpoint | Real estate & proptech | May 2017 | None on file |
| Aptinyx | Biotech & pharma | May 2016 | Bain Capital Life Sciences, New Leaf |
| Orbus Therapeutics | Biotech & pharma | August 2015 | None on file |
| SutroVax | Biotech & pharma | July 2015 | None on file |
| Rock Starr | Not yet classified | May 2015 | None on file |
| Aimmune Therapeutics | Biotech & pharma | January 2015 | None on file |
| INFACARE PHARMACEUTICAL | Biotech & pharma | October 2014 | None on file |
| CARDIODX | Biotech & pharma | July 2014 | None on file |
| Esperion Therapeutics | Biotech & pharma | June 2014 | Domain Partners |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Patrick Enright on the board, based on 17 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.